Protein kinase Czeta: not-so-innocent bystander or unusual suspect in kidney transplant rejection?
Related Experiment Video
Updated: Jun 18, 2026

Mouse Kidney Transplantation: Models of Allograft Rejection
Published on: October 11, 2014
1Nephrology and Hypertension Section, Children's Hospital Medical Center, Cincinnati, Ohio 45229-3039, USA. jens.goebel@cchmc.org
Abstract:
Antibodies against non-HLA targets are increasingly recognized in the context of transplant rejection. However, their specific role remains largely elusive, as evidence exists supporting both their occurrence as an epiphenomenon and their actual pathogenicity in the rejection process. Sutherland et al. describe protein kinase Czeta as a novel, non-HLA antigenic target in the setting of graft rejection.
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Kidney Transplant III: Nursing Management
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Acute Kidney Injury IV: Diagnostic Studies and Prevention
